logo

For the Inventor, By the Inventor

Mystic, CT, United States of America

Reinhard Sarges

USPTO Granted Patents = 47

Average Co-Inventor Count = 1.4

ph-index = 11

Forward Citations = 441(Granted Patents)


Company Filing History:

goldMedal47 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1976-1999

Loading Chart...
Areas of Expertise:
Glycogen Phosphorylase Inhibitors
Aminoquinoline Derivatives
Indolinone Derivatives
Imidazolidinedione Derivatives
Neuroleptic Agents
Chiral Hydantoins
Hydantoin Therapeutic Agents
Spiro-Imide Derivatives
Piperidine Compounds
Combination Therapy
Phenyl Substituted Compounds
Diabetes Treatment
47 patents (USPTO):Explore Patents
1. 5998463 - Glycogen phosphorylase inhibitors (1999-12-07),
2. 5362743 - Aminoquinoline derivatives (1994-11-08),
3. 5064852 - Indolinone derivatives (1991-11-12),
4. 5011840 - Imidazolidinedione derivatives in diabetes treatment (1991-04-30),
5. 4980357 - Azolidinedione derivatives (1990-12-25),
6. 4977178 - Method of treating anxiety and depression with (1990-12-11),
7. 4960785 - Indolinone derivatives (1990-10-02),
8. 4940708 - 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, (1990-07-10),
9. 4879391 - 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents (1989-11-07),
10. 4861880 - 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents (1989-08-29),
11. 4623728 - Intermediates for 1,3-disubstituted piperidine compounds as neuroleptic (1986-11-18),
12. 4623725 - [1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives (1986-11-18),
13. 4593037 - 1,3-disubstituted piperidine compounds as neuroleptic agents (1986-06-03),
14. 4547501 - Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as (1985-10-15),
15. 4495187 - Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as (1985-01-22),

Title: Innovations and Contributions of Reinhard Sarges in Pharmaceutical Patents

Introduction

Reinhard Sarges, based in Mystic, Connecticut, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 47 patents, his work primarily focuses on developing compounds that have substantial therapeutic effects and utilities in treating various medical conditions.

Latest Patents

Among his latest innovations, Reinhard developed inhibitors for glycogen phosphorylase. This invention encompasses certain 5-acyl-2-oxo-indole-3-carboxamides that serve as effective inhibitors for glycogen phosphorylase, with applications in treating diseases and conditions associated with glycogen phosphorylase dependency. Additionally, these compounds can be combined with antidiabetic agents in pharmaceutical compositions for enhanced therapeutic efficacy.

Another notable patent involves aminoquinoline derivatives. Reinhard's research culminated in the development of novel 3-acyl-4-amino-8-alkoxyquinoline compounds, along with their pharmaceutically acceptable salts. These compounds have been shown to inhibit gastric acid secretion in mammals, making them valuable in therapy as anti-ulcer agents. Furthermore, they hold promise in treating osteoporosis in afflicted subjects, with methods for preparing these compounds from known starting materials included in the patent.

Career Highlights

Reinhard currently works at Pfizer Corporation, a leading company in the pharmaceutical industry. His position at Pfizer has allowed him to contribute significantly to the development of innovative therapeutic agents. His skill and dedication have led to advancements that are both innovative and vital in addressing health care challenges.

Collaborations

Throughout his career, Reinhard has collaborated with notable coworkers such as John L. Belletire and Harry R. Howard, Jr. These partnerships have fostered a collaborative environment conducive to innovation, enhancing the impact of their combined expertise in pharmaceutical research and development.

Conclusion

Reinhard Sarges exemplifies the spirit of innovation within the pharmaceutical industry. His 47 patents reflect a commitment to improving health outcomes through scientific research and the development of novel therapeutic agents. His contributions continue to play a pivotal role in advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…